Market
Scenario
Cardiac
tamponade, is the build-up of fluid in the sac around the heart (pericardium)
resulting in pressure and difficulty in compression of the heart which results
in reduced blood volume to be pumped by the heart. The symptoms of cardiac
tamponade include shortness of breath, weakness, light-headedness, cough,
fatigue, swelling of the abdomen and veins in the arms or legs, or other areas,
pale, blue or grey-tinted skin, rapid heartbeat, anxiety or restlessness,
fainting etc. The causes of cardiac tamponade are cancer, kidney failure, chest
trauma, pericarditis, connective tissue diseases, hypothyroidism, aortic
rupture, post-operative consequences of cardiac surgery, tuberculosis etc.
Cardiac tamponade can be life-threatening if not treated. Risk factors which
increases the chances of cardiac tamponade include heart surgery, heart attack,
injury to the heart, end-stage lung cancer, radiation therapy to the chest,
hypothyroidism, systemic lupus erythematosus etc.
Diagnosis
for this disorder is mostly based on x-ray, computed tomography (CT),
Magnetic Resonance Imaging (MRI), coronary angiography, etc. The diagnosis may
be further supported by ultrasound of the heart. Magnetic resonance imaging
(MRI) is the diagnostic test of choice. The surgery segment is led by
pericardiocentesis which involves drainage of the fluid by use of a needle.
Cardiac tamponade occurs in approximately 2 per 10,000 individuals annually in
the US alone.
The
market drivers for cardiac tamponade market are, increasing cardiac cases such
as heart attack, cancer, kidney failure, end-stage lung cancer, hypothyroidism,
rising screening and penetration of healthcare, growing awareness about cardiac
diseases and growing income and healthcare expenditure etc. The market
restraints are cost of cardiac tamponade surgery, complications and risk of the
surgery along with invasive nature of this treatment.
The
global cardiac tamponade market is expected to reach US$ 5.5 billion by 2023,
and the market is projected to grow at a CAGR of ~ 5.5 % during the forecast
period 2017-2023.
Intended Audience
Global Cardiac
tamponade treatment manufacturers & suppliers
Research and development
(R&D) companies
Hospitals and
clinics
Academic institutes
and universities
Segments:
The global cardiac tamponade market has been segmented on the basis of diagnosis, treatment, and end users.
The global cardiac tamponade market has been segmented on the basis of diagnosis, treatment, and end users.
Based on
diagnosis, the market has been segmented as x-ray, computed tomography (CT),
magnetic resonance imaging (MRI), coronary angiography, electrocardiogram (EKG)
and others.
Based on
treatment, the market has been segmented as surgery and drugs. The surgery
segment has been sub-segmented as pericardiocentesis, thoracotomy and others.
The drugs segment has been sub-segmented as antibiotics, blood volume expanders
and others.
Based on
the end users, the market has been segmented as hospitals & clinics,
academic and research and others.
Regional analysis:
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new drugs in the US drives the cardiac tamponade market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The large expenditure by the US on healthcare accounting to 16% of GDP also cruises the sale of cardiac tamponade treatment. The large number of specialized cardiac centres in the US also drives the market.
Europe is
the second largest market in the world due to high income and healthcare
penetration. Europe is led by countries such as Germany and France. UK is
expected to be the fastest growing market.
Asia Pacific
region is expected to grow rapidly and China and India are likely to lead this
market due to fast growing healthcare sector during the forecast period.
Gulf
nations such as Saudi Arabia and the UAE are estimated to drive the Middle East
& African market. The development of large hospitals such as the King Fahd
hospital in Riyadh is driving the market. The African region is expected to
witness a moderate growth owing to poor economic and political conditions and
poor healthcare development.
Key Players in the Global Cardiac tamponade Market
Some of key players profiled in the report are Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical Inc., Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthcare Private Limited, Toshiba Medical Systems Corporation, General Electric Company, and others.
Detailed
Table of Contents:
1. Introduction
1.1
Definition
1.2
Scope Of Study
1.2.1
Research Objective
1.2.2
Assumptions & Limitations
1.2.2.1
Assumptions
1.2.2.2
Limitations
1.3
Market Structure
2. Research Methodology
2.1
Research Process
2.2
Primary Research
2.3
Secondary Research
9. Competitive Landscape
9.1
Major Strategies Adopted By Market Players
9.1.1
Strategic Partnership
9.1.2
Merger & Acquisition
11. Conclusion
11.1
Key Findings
11.1.1
From CEO’s Viewpoint
11.1.2
Unmet Needs Of The Market
11.2
Key Companies To Watch
11.3
Prediction Of Cardiac Tamponade Industry
...Continued
About US:
Market Research Future (MRFR), enable customers
to unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment